Citigroup’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$179K Sell
6,937
-1,313
-16% -$33.9K ﹤0.01% 3404
2025
Q1
$84.2K Sell
8,250
-926
-10% -$9.45K ﹤0.01% 3923
2024
Q4
$128K Buy
9,176
+501
+6% +$6.99K ﹤0.01% 3862
2024
Q3
$169K Buy
8,675
+5,998
+224% +$117K ﹤0.01% 3692
2024
Q2
$49.8K Buy
2,677
+2,672
+53,440% +$49.7K ﹤0.01% 3849
2024
Q1
$73 Sell
5
-23,843
-100% -$348K ﹤0.01% 4708
2023
Q4
$202K Buy
23,848
+18,649
+359% +$158K ﹤0.01% 3183
2023
Q3
$46.4K Buy
5,199
+4,951
+1,996% +$44.2K ﹤0.01% 3476
2023
Q2
$2.14K Sell
248
-5,553
-96% -$48K ﹤0.01% 4540
2023
Q1
$61.2K Sell
5,801
-2,839
-33% -$29.9K ﹤0.01% 3574
2022
Q4
$293K Sell
8,640
-272
-3% -$9.22K ﹤0.01% 2854
2022
Q3
$428K Sell
8,912
-2,914
-25% -$140K ﹤0.01% 2697
2022
Q2
$674K Sell
11,826
-1,312
-10% -$74.8K ﹤0.01% 2385
2022
Q1
$1.06M Buy
13,138
+5,159
+65% +$417K ﹤0.01% 2284
2021
Q4
$1.62M Buy
7,979
+3,900
+96% +$790K ﹤0.01% 2132
2021
Q3
$1.1M Sell
4,079
-2,020
-33% -$544K ﹤0.01% 2325
2021
Q2
$1.57M Buy
6,099
+1,724
+39% +$444K ﹤0.01% 2279
2021
Q1
$1.31M Sell
4,375
-3,145
-42% -$944K ﹤0.01% 2195
2020
Q4
$1.92M Sell
7,520
-501
-6% -$128K ﹤0.01% 1737
2020
Q3
$2M Sell
8,021
-2,054
-20% -$511K ﹤0.01% 1515
2020
Q2
$3.5M Sell
10,075
-928
-8% -$322K ﹤0.01% 1271
2020
Q1
$2.95M Buy
11,003
+4,375
+66% +$1.17M ﹤0.01% 1181
2019
Q4
$2.15M Sell
6,628
-5,621
-46% -$1.82M ﹤0.01% 1623
2019
Q3
$3.35M Buy
12,249
+6,629
+118% +$1.81M ﹤0.01% 1278
2019
Q2
$3M Sell
5,620
-1,687
-23% -$901K ﹤0.01% 1359
2019
Q1
$3.68M Sell
7,307
-1,584
-18% -$798K ﹤0.01% 1150
2018
Q4
$4.38M Buy
8,891
+2,910
+49% +$1.43M ﹤0.01% 1075
2018
Q3
$5.47M Buy
5,981
+5,664
+1,787% +$5.18M ﹤0.01% 959
2018
Q2
$232K Sell
317
-2,116
-87% -$1.55M ﹤0.01% 2845
2018
Q1
$3.88M Buy
2,433
+2,316
+1,979% +$3.69M ﹤0.01% 1098
2017
Q4
$105K Sell
117
-7,745
-99% -$6.95M ﹤0.01% 3375
2017
Q3
$2.83M Sell
7,862
-5,691
-42% -$2.05M ﹤0.01% 1274
2017
Q2
$3.98M Buy
13,553
+569
+4% +$167K ﹤0.01% 1066
2017
Q1
$4.57M Sell
12,984
-5,840
-31% -$2.06M ﹤0.01% 964
2016
Q4
$3.47M Buy
18,824
+11,562
+159% +$2.13M ﹤0.01% 1341
2016
Q3
$1.87M Buy
7,262
+2,643
+57% +$681K ﹤0.01% 1447
2016
Q2
$985K Sell
4,619
-1,857
-29% -$396K ﹤0.01% 1691
2016
Q1
$1.34M Buy
6,476
+5,983
+1,214% +$1.23M ﹤0.01% 1793
2015
Q4
$125K Sell
493
-2,245
-82% -$569K ﹤0.01% 3417
2015
Q3
$450K Buy
2,738
+1,980
+261% +$325K ﹤0.01% 2275
2015
Q2
$141K Sell
758
-1,195
-61% -$222K ﹤0.01% 3011
2015
Q1
$322K Sell
1,953
-1,262
-39% -$208K ﹤0.01% 2605
2014
Q4
$747K Buy
3,215
+2,882
+865% +$670K ﹤0.01% 2058
2014
Q3
$60K Buy
333
+168
+102% +$30.3K ﹤0.01% 3547
2014
Q2
$33K Sell
165
-1,674
-91% -$335K ﹤0.01% 3843
2014
Q1
$335K Sell
1,839
-1,354
-42% -$247K ﹤0.01% 2430
2013
Q4
$544K Buy
3,193
+1,066
+50% +$182K ﹤0.01% 2296
2013
Q3
$333K Buy
2,127
+1,009
+90% +$158K ﹤0.01% 2250
2013
Q2
$193K Buy
+1,118
New +$193K ﹤0.01% 2760